Provention Bio, Inc.
(NASDAQ : PRVB)

... ...
Daily Pre-Market Movers
Receive our daily pre-market mover email, free.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
PFEPfizer Inc. -0.11%36.710.9%$1248.49m
JNJJohnson & Johnson -0.23%160.280.7%$1180.84m
MRKMerck & Co., Inc. 1.47%83.380.7%$793.32m
ABBVAbbVie, Inc. -1.02%110.491.9%$741.62m
LLYEli Lilly & Co. 2.20%190.791.1%$736.86m
BMYBristol-Myers Squibb Co. 0.82%66.561.0%$715.48m
AZNAstraZeneca Plc 0.10%51.341.2%$669.12m
RPRXRoyalty Pharma Plc 1.37%51.950.2%$220.52m
VTRSViatris, Inc. -1.50%17.050.0%$200.69m
ARCTArcturus Therapeutics Holdings, Inc. -4.14%59.690.0%$197.04m
NVSNovartis AG 1.07%95.630.2%$176.60m
GSKGlaxoSmithKline Plc 0.80%38.470.2%$144.27m
SNYSanofi 0.73%49.390.2%$114.02m
RGENRepligen Corp. 1.52%215.476.9%$81.99m
NVONovo Nordisk A/S 1.41%72.030.1%$74.66m

Company Profile

Provention Bio, Inc. is a clinical-stage biopharmaceutical company, which engages in the development and commercialization of novel therapeutics and solutions. Its products include PRV-031 for the interception of type 1 diabetes (T1D); PRV-015 for the treatment of gluten-free diet non-responding celiac disease; PRV-6527 for Crohn’s disease; PRV-3279 for the treatment of lupus; and PRV-101 for the prevention of acute coxsackie virus B (CVB), and the prevention of type 1 diabetes (T1D) onset. The company was founded by Francisco Leon and Ashleigh Palmer on October 4, 2016 and is headquartered in Lebanon, NJ.